Xiaochun Zheng

fujian medical university

H指数:10

被引数:300

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrating pharmacovigilance and machine learning: bleeding signal detection and risk prediction for oral anticoagulants in cancer patients

整合药物警戒与机器学习：癌症患者口服抗凝剂的出血信号检测和风险预测

Research and Practice in Thrombosis and Haemostasis

IF3.4

2026-08-010

OAAI

Effects of Chardonnay grape skin residue on the chemical, sensory and nutritional value of Cabernet Sauvignon wine

霞多丽葡萄皮渣对赤霞珠葡萄酒化学、感官和营养价值的影响

Food Chemistry: X

IF0

2025-09-190

OAAI

Post-Marketing Safety Concerns with Efgartigimod alfa: A Pharmacovigilance Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database

Efgartigimod alfa上市后安全性问题：基于美国食品药品监督管理局不良事件报告系统数据库的药物警戒分析

Clinical Epidemiology

IF5.2

2025-09-160

Rhodotorula Yeasts as Potential Chassis for Sustainable Food Biotechnology

红酵母作为可持续食品生物技术的潜在底盘

Journal of Agricultural and Food Chemistry

IF6.2

2025-07-230

PRE

Effect of vacuum distillation, concentrated grape juice and oak barrel aging on the chemical, sensory and nutritional value of Marselan low-alcohol wine

真空蒸馏、浓缩葡萄汁和橡木桶陈酿对马瑟兰低酒精葡萄酒化学、感官和营养价值的影响

Food Chemistry

IF9.8

2025-07-130

PRE

Safety assessment of proteasome inhibitors real world adverse event analysis from the FAERS database

SCIENTIFIC REPORTS

IF3.9

2025-04-040

OAAI

Serum-derived exosomal microRNAs as biomarkers for postoperative delirium

血清来源的外泌体microRNAs作为术后谵妄的生物标志物

FRONTIERS IN NEUROSCIENCE

IF3.2

2025-02-280

OAAI

Metabolic Engineering of Rhodotorula toruloides for the Production of Linalool

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

IF6.2

2025-02-190

PRE

输血相关急性肺损伤：从机制洞察到治疗策略

ADVANCED SCIENCE

IF14.1

2025-01-210

De Novo Biosynthesis of 2-Phenylethanol by Metabolic Engineering the Oleaginous Yeast Rhodotorula toruloides

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

IF6.2

2024-11-061

PRE

Targeting mast cell activation alleviates anti-MHC I antibody and LPS-induced TRALI in mice by pharmacologically blocking the TLR3 and MAPK pathway

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-11-011

OAAI

cost-effectiveness of aumolertinib as first-line treatment for EGFR-mutated advanced nonsmall-cell lung cancer

奥罗替尼作为EGFR突变的晚期非小细胞肺癌一线治疗的成本效益

FUTURE ONCOLOGY

IF2.6

2024-09-200

PRE

Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database

clinical epidemiology

IF3.2

2024-09-011

OAAI

Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis

BMC CANCER

IF3.4

2024-05-292

OAAI

Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory Diseases

LC-MI-3的发现: Interleukin-1受体相关激酶4的有效和口服生物降解剂，用于治疗炎症性疾病

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-05-090

PRE

Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression

CANCER BIOLOGY & THERAPY

IF4.6

2022-09-255

OAAI

Acceptability of Drugs in the Treatment of Unresectable/Metastatic BRAF V600-Mutant Melanoma: A Systematic Review and Network Meta-Analysis

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-212

OAAI

Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation

基于生物信息学预测和验证的前列腺癌转移相关新关键基因的鉴定

CANCER CELL INTERNATIONAL

IF6

2021-10-2512

OAAI

Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer

PHYTOMEDICINE

IF8.3

2021-05-0131

PREAI

HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1

CANCER LETTERS

IF10.1

2021-03-0130

PREAI

Xiaochun Zheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向